Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 2
1951 1
1953 1
1967 1
1968 1
1969 1
1971 1
1972 7
1975 2
1976 3
1977 2
1989 1
1990 1
1991 1
1992 2
1993 1
1997 2
1998 2
1999 1
2000 3
2001 2
2002 2
2003 5
2004 9
2005 8
2006 9
2007 5
2008 10
2009 6
2010 10
2011 15
2012 13
2013 15
2014 28
2015 35
2016 26
2017 42
2018 33
2019 38
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

309 results
Results by year
Filters applied: . Clear all
Page 1
International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.
Altassan R, Péanne R, Jaeken J, Barone R, Bidet M, Borgel D, Brasil S, Cassiman D, Cechova A, Coman D, Corral J, Correia J, de la Morena-Barrio ME, de Lonlay P, Dos Reis V, Ferreira CR, Fiumara A, Francisco R, Freeze H, Funke S, Gardeitchik T, Gert M, Girad M, Giros M, Grünewald S, Hernández-Caselles T, Honzik T, Hutter M, Krasnewich D, Lam C, Lee J, Lefeber D, Marques-de-Silva D, Martinez AF, Moravej H, Õunap K, Pascoal C, Pascreau T, Patterson M, Quelhas D, Raymond K, Sarkhail P, Schiff M, Seroczyńska M, Serrano M, Seta N, Sykut-Cegielska J, Thiel C, Tort F, Vals MA, Videira P, Witters P, Zeevaert R, Morava E. Altassan R, et al. J Inherit Metab Dis. 2019 Jan;42(1):5-28. doi: 10.1002/jimd.12024. J Inherit Metab Dis. 2019. PMID: 30740725
The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild adulthood presentation limited to minor neurological involvement. ...This guideline mainly addresses the …
The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with …
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C. Ovadia C, et al. Lancet. 2019 Mar 2;393(10174):899-909. doi: 10.1016/S0140-6736(18)31877-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30773280 Free PMC article.
Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T, Skopkova M, Stanik J, Gasperikova D. Valkovicova T, et al. Endocr Regul. 2019 Apr 1;53(2):110-134. doi: 10.2478/enr-2019-0013. Endocr Regul. 2019. PMID: 31517624 Review.
Although there are some clinical instructions, HNF1A-MODY patients often do not meet every diagnostic criteria or they are still misdiagnosed as type 1 and type 2 diabetics. ...The most actual problem is classification of variants with uncertain significance (VUS) which is …
Although there are some clinical instructions, HNF1A-MODY patients often do not meet every diagnostic criteria or they are still misd …
Retracted: The effect of coenzyme A capsule on serum triglyceride concentration in patients with hypertriglyceridemia: results of a multicenter clinical trial.
[No authors listed] [No authors listed] J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):NP1. doi: 10.1177/1074248412474491. Epub 2013 Feb 19. J Cardiovasc Pharmacol Ther. 2013. PMID: 23426377
Retraction notice for "The Effect of Coenzyme A Capsule on Serum Triglyceride Concentration in Patients with Hypertriglyceridemia: Results of a Multicenter Clinical Trial" by Tianming Xuan, Bifeng Wu, Yunpeng Shang, Jiangtao Lai, Xiaosheng Hu, Zhong Liu, and Junzhu Chen Th …
Retraction notice for "The Effect of Coenzyme A Capsule on Serum Triglyceride Concentration in Patients with Hypertriglyceridemia: Results o …
Translational highlights from the journal of clinical endocrinology & metabolism.
[No authors listed] [No authors listed] Mol Endocrinol. 2011 Nov;25(11):1978-9. doi: 10.1210/mend.25.11.zmg1978. Mol Endocrinol. 2011. PMID: 22034475 Free PMC article. No abstract available.
Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance.
Zhou M, Shao J, Wu CY, Shu L, Dong W, Liu Y, Chen M, Wynn RM, Wang J, Wang J, Gui WJ, Qi X, Lusis AJ, Li Z, Wang W, Ning G, Yang X, Chuang DT, Wang Y, Sun H. Zhou M, et al. Diabetes. 2019 Sep;68(9):1730-1746. doi: 10.2337/db18-0927. Epub 2019 Jun 5. Diabetes. 2019. PMID: 31167878 Free PMC article.
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL. Hygum K, et al. Eur J Endocrinol. 2017 Mar;176(3):R137-R157. doi: 10.1530/EJE-16-0652. Eur J Endocrinol. 2017. PMID: 28049653 Review.
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
Infante M, Fabi A, Cognetti F, Gorini S, Caprio M, Fabbri A. Infante M, et al. J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. doi: 10.1186/s13046-018-1001-2. J Exp Clin Cancer Res. 2019. PMID: 30621730 Free PMC article. Review.
This review focuses on molecular mechanisms linking RANKL/RANK/OPG system to mammary tumorigenesis, highlighting pre-clinical and clinical evidence for the potential efficacy of RANKL inhibition as a prevention strategy and adjuvant therapy in breast cancer settings …
This review focuses on molecular mechanisms linking RANKL/RANK/OPG system to mammary tumorigenesis, highlighting pre-clinical and …
Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism.
Handelsman DJ, Wartofsky L. Handelsman DJ, et al. J Clin Endocrinol Metab. 2013 Oct;98(10):3971-3. doi: 10.1210/jc.2013-3375. J Clin Endocrinol Metab. 2013. PMID: 24098015 No abstract available.
Adipose mTORC1 Suppresses Prostaglandin Signaling and Beige Adipogenesis via the CRTC2-COX-2 Pathway.
Zhang X, Luo Y, Wang C, Ding X, Yang X, Wu D, Silva F, Yang Z, Zhou Q, Wang L, Wang X, Zhou J, Boyd N, Spafford M, Burge M, Yang XO, Liu M. Zhang X, et al. Cell Rep. 2018 Sep 18;24(12):3180-3193. doi: 10.1016/j.celrep.2018.08.055. Cell Rep. 2018. PMID: 30232001 Free PMC article.
309 results
Jump to page
Feedback